Cumulus Neuroscience partnered with Brandsymbol to develop a name for its advanced, at-home flexible data collection and analytics platform designed for CNS assessments. Built to support modern clinical trials, the NeuLogiq® Platform enables frequent, reliable longitudinal monitoring of brain function both in-clinic and at home.

To ensure the name aligned with scientific credibility, innovation, and long-term brand strategy, Cumulus Neuroscience partnered with Brandsymbol to lead the end-to-end naming process, including strategy, creative development, and validation.

The selected name, NeuLogiq®, was designed to convey a shift in how CNS trials and assessments are conducted. The name is both descriptive and suggestive.

• • Anchored in “Neuro” to signal neuroscience
  • While “Logiq” suggests a new way of thinking and problem-solving
  • Reinforced by the “IQ” reference to intelligence and advanced analytics

The name reflects both the platform’s scientific rigor and its role in redefining CNS trial execution. This engagement reinforces Brandsymbol’s role as a strategic partner in complex scientific and technology-driven naming programs, helping clients develop brands that balance clarity, innovation, and credibility.

Learn more about the message in a brand name: telling the product story in pharmaceutical naming

NeuLogiq™ Platform: Advancing CNS Clinical Trials Through Intelligent, At-Home Assessment